Drug Trial Radar · NCT07645248
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
Dec 28, 2026
Study completion Dec 28, 2026
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Jun 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to generate additional safety data on the propellant component of the reformulated product by comparing metered dose inhaler (MDIs) containing HFA-152a (test) with HFA-134a (reference).
Conditions
- Asthma
Interventions
HFA-152aDrug
HFA-152a will be administered.
HFA-134aDrug
HFA-134a will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events (AEs)Time frame: Up to 8 weeks
Locations
20 sites in 4 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Aventura, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Naples, Florida · Recruiting
GSK Investigational Site
Owensboro, Kentucky · Recruiting
GSK Investigational Site
Columbia, Missouri · Recruiting
GSK Investigational Site
Henderson, Nevada · Recruiting
GSK Investigational Site
Medford, Oregon · Recruiting
GSK Investigational Site
Spartanburg, South Carolina · Recruiting
GSK Investigational Site
Spartanburg, South Carolina · Recruiting
GSK Investigational Site
Cypress, Texas · Recruiting
GSK Investigational Site
Tomball, Texas · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina · Recruiting
GSK Investigational Site
Lujan de Cuyo, Argentina · Recruiting
GSK Investigational Site
Ajax, Ontario, Canada · Recruiting
GSK Investigational Site
Québec, Quebec, Canada · Recruiting
GSK Investigational Site
Trois-Rivières, Quebec, Canada · Recruiting
GSK Investigational Site
Greater Manchester, United Kingdom · Recruiting
GSK Investigational Site
Great Cambourne, Cambridge, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.